Table 3. Risk factors for hospital admission in children infected with Mycoplasma pneumoniae, Ohio, USA, 2015–2019*.
| Risk factor | Univariate analysis |
Multivariable analysis |
||||
|---|---|---|---|---|---|---|
| OR (95% CI) | p value | aOR (95% CI) |
p value | |||
| Female sex | 0.99 (0.64–1.53) | 0.9599 | ||||
| Age, y | 0.96 (0.92–1.01) | 0.1125 | 0.928 (0.877–0.982) | 0.0096 | ||
| Underlying condition | 3.47 (2.21–5.46) | <0.0001 | 4.234 (2.506–7.155) | <0.0001 | ||
| Any previous visit | 3.6 (2.24–5.78) | <0.0001 | 2.094 (1.131–3.877) | 0.0188 | ||
| Macrolide resistance | 1.55 (0.49–4.92) | 0.4547 | 1.171 (0.324–4.231) | 0.8094 | ||
| Abnormal respiratory examination | 4.31 (2.55–7.26) | <0.0001 | 4.063 (2.291–7.204) | <0.0001 | ||
| Previous treatment with antimicrobial drugs | 3.03 (1.9–4.83) | <0.0001 | 2.606 (1.377–4.934) | 0.0033 | ||
| Previous nonmacrolide antimicrobial drugs | 2.85 (1.78–4.56) | <0.0001 | ||||
| Positive viral test | 0.24 (0.08–0.68) | 0.0071 | ||||
| MRMp and positive viral test | 0.23 (0.04–1.44) | 0.1166 | ||||
*Bold type indicates statistical significance. aOR, adjusted OR; MRMp: macrolide-resistant Mycoplasma pneumoniae; OR, odds ratio.